A Connecticut-based healthcare company is turning heads on Thursday after it was announced that its subsidiary was selected to join NVIDIA Inception , a program designed to partner with companies revolutionizing industries with advancements in artificial intelligence (AI) and data sciences, according to the release.

This caused traders to become eager to get their hands on shares of the parent company BioSig Technologies Inc. (Nasdaq:BSGM) during Thursday’s premarket hours. At the time of writing, traders are bid for shares of $BSGM at $1.44/share, which is an implied open +10.77% above yesterday’s close of $1.30. It should be an exciting session for this small cap!

BioSig Technologies is an advanced medical technology company bringing never-before-seen insights to the treatment of cardiovascular arrhythmias. Through collaboration with physicians, experts, and healthcare leaders across the field of electrophysiology (EP), BioSig is committed to addressing healthcare’s biggest priorities-saving time, saving costs, and saving lives. The Company’s first product, the PURE EP¿ System, an FDA 510(k) cleared non-invasive class II device, provides superior, real-time signal visualization allowing physicians to perform insight-based, highly targeted cardiac ablation procedures with increased procedural efficiency and efficacy. The global EP market is projected to reach $16B in 2028 with an 11.2% growth rate.

Copyright © 2023 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.